Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-06

Clinical Trial Update: Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating mesenchymal stem cell implantation for degenerative disc disease with related low back pain; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Ahmad Jabir Rahyussalim | Conditions: Degenerative Disc Disease, Low Back Pain | Phase 2 | Status: UNKNOWN